期刊文献+

儿童肾母细胞瘤相关基因CTNNB1和WT1突变的初步研究 被引量:1

Studies on CTNNB1 and WT1 mutations in pediatric patients with Wilm's tumor
原文传递
导出
摘要 目的观察CTNNB1和WT1基因在我国肾母细胞瘤患儿中的突变特点,探索基因突变与患儿临床表现之间的关系。方法随机选取我院2007年1月至2011年1月收治的肾母细胞瘤患儿50例。收集这些病例的临床资料,并对肿瘤组织和瘤旁组织的CTNNB1基因外显子3、7、8、9和WT1基因外显子1~10进行突变检测。结果CTNNB1突变15例(30%),8例突变涉及第45位点的丝氨酸编码子(TCT),其中2例完全丢失,6例错义突变。剩余7例为错义突变。wTl突变9例(18%)。移码突变4例,无义突变3例,2例碱基插入突变发生在内含子1区域。CTNNB1和WT1突变与患儿临床表现未见显著相关(P〉0.05)。CTNNBl突变与WT1突变明显相关(P〈0.002)。结论CTNNB1和WT1基因突变确实存在于我国儿童肾母细胞瘤患者中。CTNNB1突变患儿存在WT1突变概率明显高于无CTNNB1突变患儿。然而尚未发现CTNNBl和WT1突变与患儿临床表现密切相关。 Objective To investigate the CTNNB1 and WT1 mutations in Chinese pediatric pa- tients with Wilm's tumor and to explore the correlations between mutations of these two genes and the patients' clinical characteristics. Methods Fifty cases with Wiln-rs tumors who were treated in our hos- pital from Jan of 2007 to Jan of 2011 were included in this study. The clinical variables were reviewed. DNA was collected from tissue of tumor and normal kidney beside tumor. Exon 3,7-9 of CTNNB1 and exon 1-10 of WTI were sequenced. Results There were 15 (30%) cases with somatic mutations of CTNNB1. Eight mutations at codon 45 included 2 TCT deletions and 6 mis-sense mutations. The rest were 7 different mis-sense mutations. There were 9 patients (18%) with WT1 mutations including 4 frame shift and 3 nonsense mutations. The other 2 same insert mutations existed at intron 1 region. No significant correlation was found between mutations of CTNNB1/WT1 and clinical characteristics (P 〈0. 05). However there was significant correlation between CTNNB1 and WTI mutations (P = 0. 002). Conclusions Mutations of CTNNB1 and WT1 do exist in Chinese pediatric patients with Wilm's tumor. Tumors with CTNNBI mutations are more likely to have WT1 mutations. Nevertheless there is no significant correlation between clinical variahles and gene mutations.
出处 《中华小儿外科杂志》 CSCD 北大核心 2013年第8期561-566,共6页 Chinese Journal of Pediatric Surgery
关键词 肾母细胞瘤 CTNNB1基因 WT1基因 Wilms tumor CTNNB1 WT1
  • 相关文献

参考文献15

  • 1Huff V. Wilms tumours: about tumour suppressor genes, an oncogene and a chameleon gene. Nat Rev Cancer, 2011, 11 (2): 111-121.
  • 2Maiti S, Alam R, Amos CI, et al. Frequent association of beta catenin and WT1 mutations in Wilms tumors. Cancer Res, 2000,60 (22) : 6288-6292.
  • 3Yang L,Han Y, Suarez Saiz F, et al. A tumor suppressor and oncogene: the WT1 story. Leukemia,2007,21 (5) :868-876.
  • 4蒋也平,沈颖,孙宁,王辉.儿童肾母细胞瘤WT1基因突变四例报道[J].中华儿科杂志,2009,47(10):762-766. 被引量:1
  • 5Li J, Ding J, Zhao D, et al. WTI gene mutations in Chinese children with early onset nephrotie syndrome. Pediatr Res, 2010, 68(2) : 155-158.
  • 6Koesters R,Ridder R, Kopp-Schneider A, et al. Mutational activation of the beta-catenin proto-oncogene is a common event in the development of Wilms' tumors. Cancer Res, 1999, 59 (16) :3880-3882.
  • 7Su MC, Huang WC, Lien HC. Beta-catenin expression and mu tation in adult and pediatric Wilms' tumors. APMIS, 2008,116 (9): 771-778.
  • 8Li CM,Kim CE, Margolin AA, et al. CTNNB1 mutations and overexpression of Wnt/beta-eatenin target genes in WT1 mutant Wilms' tumors. Am J Pathol, 2004,165 (6) : 1943-1953.
  • 9Nordenskjold A, Friedman E, Sandstedt B, et al. Constitutional and somatic mutations in the WT1 gene in Wilms' tumor pa tients. Int J Cancer, 1995,63(4) .516-522.
  • 10Diller L, Ghahremani M, Morgan J, et al. Constitutional WT1 mutations in Wilms' tumor patients. J Clin Oneol, 1998, 16 (11) :3634-3640.

二级参考文献10

  • 1Lyndon MG, Manit A, Imran M, et al. Current challenges in Wilms' tumor management. Nature Clinical Practice Oncology, 2005, 2 : 298-304.
  • 2Yang L, Han Y, Saurez Saiz F, et al. A tumor suppressor and oncogene: the WT1 story. Leukemia, 2007, 21: 868-876.
  • 3Call KM, Glaser T, Ito CY, et al. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell, 1990, 60: 509-520.
  • 4Dey BR, Sukhatme VP, Roberts AB, et al. Repression of the Transforming growth factor-beta 1 gene by the Wilms' tumor suppressor WT1 gene product. Mol Endocrinol, 1994, 8: 595- 602.
  • 5Little M, Wells C. A clinical overview of WT1 gene mutations. Human Mutation, 1997, 9: 209-225.
  • 6Royer-Pokora B, Beier M, Henzler M, et al. Twenty-four new cases of WT1 germline mutations and review of the literature: genotype / phenotype correlations for Wilms tumor development. Am J Med Gen,2004, 127 : 249-257.
  • 7Ladomery M, Dellaire G. Muhifunetional zinc finger proteins in development and disease. Ann Hum Genet, 2002, 66:331-342.
  • 8Rivera MN, Kim WJ, Wells J, et al. An X chromosome gene, WTX, is commonly inactivated in Wilms tumor. Science, 2007, 315 : 642-645.
  • 9Barker N, Clevers H. Catenins, Wnt signaling and cancer. Bioessays, 2000, 22 : 961-965.
  • 10Ruteshouser EC, Robinson SM, Huff V. Wilms tumor genetics: mutations in WT1, WTX and CTNNB1 account for only about one- third of tumors. Gen Chrom Can, 2008, 47: 461-470.

同被引文献5

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部